Anaemia before SBRT linked to poor survival in Stage I NSCLC

Pretreatment anaemia may be predictive of aggressive disease with poor survival and non-local disease progression among patients with early-stage non-small cell lung cancer (NSCLC) undergoing stereotactic body radiation therapy (SBRT), according to a study published in the Journal of Thoracic Oncology.

Cancer Therapy Advisor